Authors:
Hunfeld, KP
Weigand, J
Wichelhaus, TA
Kekoukh, E
Kraiczy, P
Brade, V
Citation: Kp. Hunfeld et al., In vitro activity of mezlocillin, meropenem, aztreonam, vancomycin, teicoplanin, ribostamycin and fusidic acid against Borrelia burgdorferi, INT J ANT A, 17(3), 2001, pp. 203-208
Authors:
Hunfeld, KP
Wichelhaus, TA
Kekoukh, E
Molitor, M
Kraiczy, P
Brade, V
Citation: Kp. Hunfeld et al., In vitro susceptibility of the Borrelia burgdorferi sensu lato complex to ABT-773, a novel ketolide, J ANTIMICRO, 48(3), 2001, pp. 447-449
Authors:
Woessner, R
Gaertner, BC
Grauer, MT
Weber, K
Mueller-Lantzsch, N
Hunfeld, KP
Trieb, J
Citation: R. Woessner et al., Incidence and prevalence of infection with human granulocytic ehrlichiosisagent in Germany. A prospective study in young healthy subjects, INFECTION, 29(5), 2001, pp. 271-273
Authors:
Kraiczy, P
Weigand, J
Wichelhaus, TA
Heisig, P
Backes, H
Schafer, V
Acker, G
Brade, V
Hunfeld, KP
Citation: P. Kraiczy et al., In vitro activities of fluoroquinolones against the spirochete Borrelia burgdorferi, ANTIM AG CH, 45(9), 2001, pp. 2486-2494
Authors:
Hunfeld, KP
Kraiczy, P
Wichelhaus, TA
Schafer, V
Brade, V
Citation: Kp. Hunfeld et al., New colorimetric microdilution method for in vitro susceptibility testing of Borrelia burgdorferi against antimicrobial substances, EUR J CL M, 19(1), 2000, pp. 27-32
Authors:
Hunfeld, KP
Kraiczy, P
Wichelhaus, TA
Schafer, V
Brade, V
Citation: Kp. Hunfeld et al., Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates, INT J ANT A, 15(1), 2000, pp. 11-17
Authors:
Kraiczy, P
Hunfeld, KP
Breitner-Ruddock, S
Wurzner, R
Acker, G
Brade, V
Citation: P. Kraiczy et al., Comparison of two laboratory methods for the determination of serum resistance in Borrelia burgdorferi isolates, IMMUNOBIOL, 201(3-4), 2000, pp. 406-419
Authors:
Hunfeld, KP
Schmidt, C
Krackhardt, B
Posselt, HG
Bargon, J
Yahaf, Y
Schafer, V
Brade, V
Wichelhaus, TA
Citation: Kp. Hunfeld et al., Risk of Pseudomonas aeruginosa cross-colonisation in patients with cystic fibrosis within a holiday camp - a molecular-epidemiological study, WIEN KLIN W, 112(7), 2000, pp. 329-333
Authors:
Kraiczy, P
Hunfeld, KP
Peters, S
Wurzner, R
Acker, G
Wilske, B
Brade, V
Citation: P. Kraiczy et al., Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant, J MED MICRO, 49(10), 2000, pp. 917-928
Citation: Kp. Hunfeld et V. Brade, Prevalence of antibodies against the human granulocytic ehrlichiosis agentin Lyme borreliosis patients from Germany, EUR J CL M, 18(3), 1999, pp. 221-224
Authors:
Wichelhaus, TA
Kern, S
Schafer, V
Brade, V
Hunfeld, KP
Citation: Ta. Wichelhaus et al., Evaluation of modern agglutination tests for identification of methicillin-susceptible and methicillin-resistant Staphylococcus aureus, EUR J CL M, 18(10), 1999, pp. 756-758
Authors:
Hunfeld, KP
Allwinn, R
Peters, S
Kraiczy, P
Brade, V
Citation: Kp. Hunfeld et al., Serologic evidence for tick-borne pathogens other than Borrelia burgdorferi (TOBB) in Lyme borreliosis patients from midwestern Germany, WIEN KLIN W, 110(24), 1998, pp. 901-908